胺衍生物作为强大的中枢神经系统多目标SERT/NET/H代理:合成和生物评估
Quxiang Li1, Lili Ren1, Dongli Wang2
1School of Pharmacy, Nanjing Tech University, 30th South Puzhu Road, Nanjing 211816, China.
Molecules (Basel, Switzerland)
|November 27, 2024
概括
化合物11b是一种新型的安非他胺衍生物,通过抑制血清素和上腺素载体并与组胺H3受体相互作用,显示出作为抗抑郁药物的前景. 它在行为研究中表现出有效性,具有有利的药理动力学特征.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 需要新的抗抑郁药物来解决当前治疗方法的局限性.
- 向血清激素和上腺素运输体 (SERT/NET) 和组胺H3受体 (H3R) 为抑郁症治疗提供了一个潜在的策略.
研究的目的:
- 合成和评估新型安非他胺衍生物作为潜在的多面抗抑郁药物.
- 调查化合物11b的药理特征,包括其载体抑制,受体亲和力和体内疗效.
主要方法:
- 新型安非他胺衍生物的合成.
- 在体外测定SERT/NET抑制和受体结合 (H3R,H1,α1).
- 分子对接研究,以预测结合模式.
- 在生体内进行行为测试 (强迫游泳测试,尾部悬浮测试) 和小鼠运动运动活动评估.
- 在老鼠中进行的药理动力学研究.
主要成果:
- 化合物11b表现出强大的SERT/NET抑制和对H3R的高度亲和力.
- 它对目标外受体 (H1,α1) 和hERG通道的亲和力较低,这表明QT延长的风险较低.
- 分子对接支持11b与SERT,NET和H3R的结合.
- 在体内研究表明,剂量取决于不动性的减少,而没有刺激运动活动.
- 化合物11b在老鼠中具有有利的药理动力学特征.
结论:
- 化合物11b显示出抗抑郁药活性有前途的药理学特征.
- 它的多方面的机制,针对SERT/NET和H3R,保证进一步开发作为一种新型抗抑郁药物药物类别.
更多相关视频
相关概念视频
01:25Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
01:16Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
01:28Adrenergic Agonists: Mixed-Action Agents
664
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
664
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
163
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
163
01:21Drugs Affecting Neurotransmitter Release or Uptake
952
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
952
01:23Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K